SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-071281
Filing Date
2023-08-28
Accepted
2023-08-28 16:55:56
Documents
2
Period of Report
2023-10-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea184268-def14a_cadrenal.htm DEF 14A 453072
2 GRAPHIC image_001.jpg GRAPHIC 4780
  Complete submission text file 0001213900-23-071281.txt   460820
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41596 | Film No.: 231216887
SIC: 2834 Pharmaceutical Preparations